Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Prostaglandin E1 measurement (procedure) |
Has measured component |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prostaglandin E1 measurement (procedure) |
Component |
True |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alprostadil |
Is a |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prostaglandin E>1< preparation (substance) |
Is a |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prostaglandin E>1< preparation (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dinoprostone 10mg pessary (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely dinoprostone 500 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
dinoprostone 1 mg/mL, ampoule de 0,75 mL de concentré pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
dinoprostone 10 mg/mL, ampoule de 0,5 mL de concentré pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dinoprostone 5mg/0.5mL extra-amniotic solution+diluent (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dinoprostone 400 microgram/mL vaginal gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dinoprostone 3 mg vaginal tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing gemeprost (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely gemeprost 1 milligram/1 each conventional release vaginal pessary (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oral dinoprostone (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dinoprostone-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing dinoprostone in vaginal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing dinoprostone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dinoprostone 10mg insert |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing alprostadil in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alprostadil 40.0mcg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil 500micrograms pellet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil 20.2mcg/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil 1000micrograms pellet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil 500mcg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil 5micrograms injection (pdr for recon)+diluent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil adverse reaction |
Causative agent (attribute) |
True |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alprostadil-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alprostadil 40micrograms injection (pdr for recon)+diluent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil 40micrograms injection cartridge continuation pack |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil 10micrograms injection cartridge continuation pack (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
alprostadil 20micrograms injection cartridge starter pack |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
alprostadil 500 microgrammes/mL, ampoule de 1 mL de concentré pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
alprostadil 10micrograms injection cartridge starter pack |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil 10.16mcg/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
alprostadil 40micrograms injection cartridge starter pack |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to alprostadil (finding) |
Causative agent (attribute) |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil 125micrograms pellet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil 250micrograms pellet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil 20micrograms injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil 20micrograms injection cartridge continuation pack (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil 10micrograms injection (pdr for recon)+diluent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil [erectile dysfunction] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil 20micrograms injection (pdr for recon)+diluent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil 10micrograms injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil 500mcg pessary |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil 250mcg suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil 125mcg suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil 1000mcg suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil 5mcg/mL powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
alprostadil 20micrograms cartridge syringe injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil 10micrograms cartridge syringe injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing alprostadil in genitourinary dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to alprostadil (finding) |
Causative agent (attribute) |
True |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alprostadil 40micrograms powder for conventional release solution for injection cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil 125 microgram urethral stick |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil 250 microgram urethral stick |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely alprostadil 500 microgram/1 each conventional release urethral stick (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil 1 mg urethral stick |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprostadil-containing product in urethral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alprostadil 10 microgram powder for solution for injection cartridge |
Has basis of strength substance (attribute) |
True |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alprostadil 10 microgram powder for solution for injection cartridge |
Has precise active ingredient |
True |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alprostadil 10 microgram powder for solution for injection vial |
Has basis of strength substance (attribute) |
True |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alprostadil 10 microgram powder for solution for injection vial |
Has precise active ingredient |
True |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alprostadil 20 microgram powder for solution for injection cartridge |
Has basis of strength substance (attribute) |
True |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alprostadil 20 microgram powder for solution for injection cartridge |
Has precise active ingredient |
True |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely alprostadil 20 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely alprostadil 20 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely alprostadil 40 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely alprostadil 40 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alprostadil 5 microgram powder for solution for injection vial |
Has precise active ingredient |
True |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alprostadil 5 microgram powder for solution for injection vial |
Has basis of strength substance (attribute) |
True |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely alprostadil 500 microgram/1 milliliter conventional release solution for infusion ampule |
Has basis of strength substance (attribute) |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely alprostadil 500 microgram/1 milliliter conventional release solution for infusion ampule |
Has precise active ingredient |
False |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only alprostadil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only alprostadil in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only alprostadil in urethral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely alprostadil 500 microgram/1 milliliter conventional release solution for infusion (clinical drug) |
Has basis of strength substance (attribute) |
True |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely alprostadil 500 microgram/1 milliliter conventional release solution for infusion (clinical drug) |
Has precise active ingredient |
True |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alprostadil 1 mg urethral stick |
Has basis of strength substance (attribute) |
True |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alprostadil 1 mg urethral stick |
Has precise active ingredient |
True |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alprostadil 250 microgram urethral stick |
Has basis of strength substance (attribute) |
True |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alprostadil 250 microgram urethral stick |
Has precise active ingredient |
True |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely alprostadil 500 microgram/1 each conventional release urethral stick (clinical drug) |
Has precise active ingredient |
True |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely alprostadil 500 microgram/1 each conventional release urethral stick (clinical drug) |
Has basis of strength substance (attribute) |
True |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alprostadil 125 microgram urethral stick |
Has basis of strength substance (attribute) |
True |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alprostadil 125 microgram urethral stick |
Has precise active ingredient |
True |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely alprostadil 20 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely alprostadil 20 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely alprostadil 10 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely alprostadil 10 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alprostadil 500 microgram/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alprostadil 500 microgram/mL solution for injection |
Has precise active ingredient |
True |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alprostadil 500 microgram/mL solution for infusion and/or injection |
Has precise active ingredient |
True |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alprostadil 500 microgram/mL solution for infusion and/or injection |
Has basis of strength substance (attribute) |
True |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely alprostadil 3 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has precise active ingredient |
True |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely alprostadil 3 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has basis of strength substance (attribute) |
True |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alprostadil-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alprostadil only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prostaglandin E1 |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |